Vaccination and allergy

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 12, Issue 3, 2004, Pages 223-231

  Rottem, Menachem ^a   Shoenfeld, Yehuda ^b,c  

^a HAEMEK MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Allergy; Asthma; Autoimmunity; Immunotherapy; Vaccine; Viral infection

Indexed keywords

BCG VACCINE; EGG PROTEIN; GELATIN; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; VACCINE;

ALLERGIC REACTION; ALLERGIC RHINITIS; ALLERGY; ASTHMA; ATOPIC DERMATITIS; ATOPY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; ECZEMA; EPIDEMIC ENCEPHALITIS; FOOD ALLERGY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION CONTROL; INFLUENZA; META ANALYSIS; MUMPS; PERTUSSIS; PRIORITY JOURNAL; RASH; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RUBELLA; SMALLPOX; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; URTICARIA; VACCINATION; VACCINIA;

ADULT; ANAPHYLAXIS; ASTHMA; AUTOIMMUNE DISEASES; BACTERIAL VACCINES; CHILD; HUMANS; HYPERSENSITIVITY; RISK; VACCINATION; VIRAL VACCINES;

EID: 2542483049     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000122312.13359.eb     Document Type: Review

References (48)

1. Zent O, Arras-Reiter C, Broeker M, et al.: Immediate allergic reactions after vaccinations-a post-marketing surveillance review. Eur J Pediatr 2002, 161:21-25.
2. Bohlke K, Davis RL, Marcy SM, et al.: Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003, 112:815-820.
3. The American Lung Association Asthma Clinical Research Centers: The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001, 345:1529-1536.
4. Zeiger RS. Current issues with influenza vaccination in egg allergy. J Allergy Clin Immunol 2002, 110:834-840.
5. Copeman PWM, Wallace HJ: Eczema vaccinatum. BMJ 1964, 2:906-908.
6. Lane JM, Millar JD: Risks of smallpox vaccination complications in the United States. Am J Epidemiol 1971, 93:238-240.
7. Engler RJ, Kenner J, Leung DY: Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 2002, 110:357-365. As the threat of bioterrorism with pathogenic microbes such as smallpox virus increases, the question of widespread voluntary vaccination with smallpox (vaccinia) vaccines is being carefully considered. A major challenge lies in the ability to protect the population from the disease while minimizing the considerable side effects from the vaccine. Individuals with active or quiescent atopic dermatitis are at increased risk for vaccinia complications. The nature of these complications and other considerations are summarized in this review.
8. Murphy JG, Wright RS, Bruce GK, et al.: Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet 2003, 362:1378-1380.
9. Chen RT, Lane JM: Myocarditis: the unexpected return of smallpox vaccine adverse events. Lancet 2003, 362:1345-1346.
10. Gruchalla RS, Jones J: Combating high-priority biological agents: what to do with drug-allergic patients and those for whom vaccination is contraindicated? J Allergy Clin Immunol 2003, 112:675-682. This article focuses on the various vaccine-related and antibiotic-related adverse effects that the allergist/immunologist might see during treatment of infections. Potential management approaches are outlined.
11. Plaut M, Tinkle SS: Risks of smallpox vaccination: 200 years after Jenner. J Allergy Clin Immunol 2003, 112:683-685. This editorial is related to the article by Gruchalla and Jones [10], which summarizes the risks of smallpox vaccination.
12. Ponvert C, Ardelean-Jaby D, Colin-Gorski AM, et al.: Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin tests and specific IgE determination. Vaccine 2001, 19:4588-4591.
13. Plesner A, Ronne T, Wachmann H, Case-control study of allergic reactions to Japanese encephalitis vaccine. Vaccine 2000, 18:1830-1836.
14. Nakayama T, Aizawa C, Kuno-Sakai H: A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. J Allergy Clin Immunol 1999, 103:321-325.
15. Sakaguchi M, Inouye S: IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines. Vaccine 2000, 18:2055-2058.
16. Sakaguchi M, Miyazawa H, Inouye S: Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines. Allergy 2001, 56:536-539.
17. Kumagai T, Ozaki T, Kamada M, et al.: Gelatin-containing diphtheria-tetanus-pertussis (DTP) vaccine causes sensitization to gelatin in the recipients. Vaccine 2000, 18:1555-1561.
18. Sakaguchi M, Miyazawa H, Inouye S: Sensitization to gelatin in children with systemic non-immediate-type reactions to varicella vaccines. Ann Allergy Asthma Immunol 2000, 84:341-344.
19. Patja A, Davidkin I, Kurki T, et al.: Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 2000, 19:1127-1234.
20. Patja A, Makinen-Kiljunen S, Davidkin I, et al.: Allergic reactions to measles-mumps-rubella vaccination. Pediatrics 2001, 107:E2.
21. Zeiger RS: Current issues with influenza vaccination in egg allergy. J Allergy Clin Immunol 2002, 110:834-840. Influenza infection, with its accompanying morbidity and mortality, represents a major public health concern yearly to the elderly and high-risk groups, including asthmatic patients. Active prevention with vaccination consistently falls short of reaching optimal immunization rates in all risk groups. Asthmatic patients and others with concomitant egg allergy might be denied active immunization because of the risk of inducing adverse reactions with a vaccine derived from egg embryo tissue. Evidence supports the relatively safe administration of influenza vaccine to individuals with egg allergy in whom vaccination is indicated when specific protocols are followed under the supervision of experienced physicians. A practical protocol that includes incremental dosing of influenza vaccine is presented to guide clinicians in influenza vaccination in this high-risk group.
22. James JM, Zeiger RS, Lestor MR, et al.: Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 1998, 133:624-628.
23. Pickering LK, ed. 2000 Red Book: Report of the Committee on Infectious Diseases. Edn 25. Elk Grove Village, IL: American Academy of Pediatrics Publications; 2000:36, 358.
24. Holt PG, Rowe J, Loh R, et al.: Developmental factors associated with risk for atopic disease: implications for vaccine strategies in early childhood. Vaccine 2003, 21:3432-3435.
25. Gruber C, Illi S, Lau S, et al.: Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 2003, 111: e282-e288. This article analyzes the prevalence of allergic sensitization and atopic disease in relation to vaccination coverage. Children with a higher vaccination coverage seem to be transiently better protected against development of atopy during their first years of life.
26. Gruber C, Nilsson L, Bjorksten B: Do early childhood immunizations influence the development of atopy and do they cause allergic reactions? Pediatr Allergy Immunol 2001, 12:296-311.
27. Choi IS, Koh YI: Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann Allergy Asthma Immunol 2002, 88:584-591.
28. Marks GB, Ng K, Zhou J, et al.: The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Ciin Immunol 2003, 111:541-549.
29. Krause TG, Hviid A, Koch A, et al.: BCG vaccination and risk of atopy. JAMA 2003, 289:1012-1015.
30. Bager P, Westergaard T, Rostgaard K, et al.: Smallpox vaccination and risk of allergy and asthma. J Allergy Clin Immunol 2003, 111:1227-1231. This article presents data that do not suggest that childhood vaccination against smallpox, even if given early in life, influences the development of atopy or allergic rhinitis.
31. Assa'ad A, Lierl M: Effect of acellular pertussis vaccine on the development of allergic sensitization to environmental allergens in adults. J Allergy Clin Immunol 2000, 105:170-175.
32. Kramarz P, Destefano F, Gargiullo PM, et al.: Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001, 138:306-310.
33. Tata U, West J, Harrison T, et al.: Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003, 58:835-839.
34. Miller RL, Cheng M, DiMango EA, et al.: T-cell responses and hypersensitivity to influenza and egg antigens among adults with asthma immunized with the influenza vaccine. J Allergy Clin Immunol 2003, 112:606-608.
35. Pershagen G: Can immunization affect the development of allergy? Pediatr Allergy Immunol 2000, 11:26-28.
36. Holt PG, Rudin A, Macaubas C, et al.: Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children. J Allergy Clin Immunol 2000, 105:1117-1122.
37. Demoley P, Ichel FB, Bousquet J: Specific immunotherapy in allergic rhinitis and asthma. In Asthma and Rhinitis. Edn 2, vol. 2. Edited by Busse WW, Holgate ST. Oxford, UK: Blackwell Science; 2000:1687-1706.
38. Spiegelberg HL, Takabayashi K, Beck L, et al.: DNA-based vaccines for allergic disease. Expert Rev Vaccines 2002, 1:169-177.
39. Horner AA, Raz E. Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases. J Allergy Clin Immunol 2002, 110:706-712.
40. Shoenfeld Y, Aron-Maor A: Vaccination and autoimmunity-" vaccinosis": a dangerous liaison? J Autoimmunity 2000, 14:1-10.
41. Borchers AT, Keen CL, Shoenfeld Y, et al.: Vaccines, viruses and voodoo. J Invest Allergy Clin Immunol 2002, 12:155-168. Vaccinations are invaluable in protecting the population from a wide variety of diseases that can cause substantial morbidity and mortality. Although a rare complication of vaccination, autoimmune disorders represent one of these morbidities. Recently, widespread public concern has arisen from case reports suggesting that (similar to what has been observed after natural viral infections) there might be an association between specific immunizations and autoimmune diseases. Review of the available data suggests that, for the general population, the risk-to-benefit ratio is overwhelmingly in favor of vaccinations. However, the possibility cannot be ruled out that in genetically susceptible individuals, vaccination can result in the unmasking of an autoimmune disease triggered by the immunization.
42. Shoenfeld Y, Aharon-Maor A, Sherer Y: Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol 2000, 18:1-4.
43. Shoenfeld Y: Vaccination and arthritis revisited. March 17, 2003. Available at www.rheuma21st.com/archives/apls_shoenfeld.vaccination_revisited_html.
44. Aharon-Maor A, Shoenfeld Y: The good, the bad and the ugly of vaccination. Isr Med Assoc J 2000, 2:225-227.
45. Shoenfeld Y, Aron-Maor A, Tanal A, et al.: BCG and autoimmunity: another two-edged sword. J Allergy Immunol 2001, 16:235-240.
46. Aron-Maor A, Shoenfeld Y: BCG immunization and the "Trojan horse" phenomenon. Clin Rheumatol 2003, 22:6-7.
47. Abu-Shakra M, Zalmanson S, Neumann L, et al.: Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol 2000, 27:1681.
48. Aron-Maor A, Shoenfeld Y: Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 2001, 10:237-240.